Wilmer Cutler Pickering Hale and Dorr advised Dyne Therapeutics, Inc., and Cooley advised the underwriters. Dyne Therapeutics, Inc. (Nasdaq:DYN) (“Dyne”) announced the closing of an underwritten public offering...
Dyne Therapeutics’ $345 Million Common Stock Offering
Gemini Therapeutics’ Combination with Disc Medicine
Wilmer Cutler Pickering Hale and Dorr advised Gemini, while Goodwin Procter advised Disc Medicine. Fried, Frank, Harris, Shriver & Jacobson acted as counsel to SVB Securities...
Apellis’ Research Collaboration With Beam Therapeutics
Wilmer Cutler Pickering Hale and Dorr advised Apellis Pharmaceuticals on the deal. Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Beam Therapeutics Inc. (Nasdaq: BEAM), announced that they...